CHRISTINA OVERLY: Open Payments
NPI 1265166318 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,619 in 106 payments from 26 companies in 2025. Trend: 2023 $2,113 · 2024 $2,433 · 2025 $2,619
Food & beverage: $2,611Education: $8
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 23 | $632 |
| Dendreon Pharmaceuticals LLC | 10 | $292 |
| Sumitomo Pharma America, Inc. | 14 | $273 |
| Calyxo, Inc. | 1 | $146 |
| Merck Sharp & Dohme LLC | 6 | $143 |
| UROGEN PHARMA, INC. | 9 | $136 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $133 |
| PFIZER INC. | 5 | $130 |
| TOLMAR, INC. | 4 | $99 |
| Olympus America Inc. | 4 | $95 |
Products named: ERLEADA, PROVENGE, ORGOVYX, CVAC ASPIRATION SYSTEM, XTANDI, Nubeqa, GEMTESA, LYNPARZA.
Industry payments across OK — which companies pay providers there.
